BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4521971)

  • 1. Sensitivity to normal brain antigens of blood lymphocytes from patients with gliomas.
    Wahlström T
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Dec; 81(6):763-7. PubMed ID: 4521971
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro demonstration of cell-mediated immunity to human brain tumors.
    Levy NL; Mahaley MS; Day ED
    Cancer Res; 1972 Mar; 32(3):477-82. PubMed ID: 4334410
    [No Abstract]   [Full Text] [Related]  

  • 3. [Frequency and significance of lymphoplasmocyte infiltration in human gliomas (author's transl)].
    Schiffer D; Croveri G; Pautasso C
    Tumori; 1974; 60(3):177-84. PubMed ID: 4372756
    [No Abstract]   [Full Text] [Related]  

  • 4. Lymphocytic infiltration in gliomas: evidence of possible host resistance.
    Ridley A; Cavanagh JB
    Brain; 1971; 94(1):117-24. PubMed ID: 5552158
    [No Abstract]   [Full Text] [Related]  

  • 5. Autoradiographic and fluorescence antibody studies of the human host immune response to gliomas.
    Eggers AE
    Neurology; 1972 Mar; 22(3):246-50. PubMed ID: 4334554
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanisms by which human gliomas may escape cellular immune attack.
    Gately MK; Glaser M; McCarron RM; Dick SJ; Dick MD; Mettetal RW; Kornblith PL
    Acta Neurochir (Wien); 1982; 64(3-4):175-97. PubMed ID: 6215833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro studies on the cell-mediated immune response to human brain tumors. I. Requirement for third-party stimulator lymphocytes in the induction of cell-mediated cytotoxic responses to allogeneic cultured gliomas.
    Gately MK; Glaser M; Dick SJ; Mettetal RW; Kornblith PL
    J Natl Cancer Inst; 1982 Dec; 69(6):1245-54. PubMed ID: 6183477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two separate membrane-bound antigens on human glioma cells in tissue culture detected with sera from glioma patients by immunofluorescence.
    Solheid C; Lauro G; Palladini G
    J Neurol Sci; 1976 Nov; 30(1):55-64. PubMed ID: 789826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological considerations and the malignant glioma problem.
    Mahaley MS
    Clin Neurosurg; 1968; 15():175-89. PubMed ID: 4333303
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cellular immunity of the patients with malignant glioma -- with special reference to the depressed cell-mediated immunity of the cerebrospinal (author's transl)].
    Uemura S; Wada S; Kodama T; Matsukado Y
    No Shinkei Geka; 1977 Aug; 5(9):931-9. PubMed ID: 303336
    [No Abstract]   [Full Text] [Related]  

  • 11. Specificity of lymphocyte-mediated cytotoxicity in patients with primary intracranial tumors.
    Levy NL
    J Immunol; 1978 Sep; 121(3):903-15. PubMed ID: 211167
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunologic sensitization to tumor-associated antigens during the growth of gliomas of the brain (experimental study)].
    Novichenko NL; Romodanov AP; Zhmareva EN; Gorovoĭ AI
    Zh Vopr Neirokhir Im N N Burdenko; 1984; (2):9-13. PubMed ID: 6741378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunobiology of human gliomas.
    Bullard DE; Gillespie GY; Mahaley MS; Bigner DD
    Semin Oncol; 1986 Mar; 13(1):94-109. PubMed ID: 2420011
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunology of brain tumors: the glial carcino-fetal antigen].
    Trouillas P
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):819-28. PubMed ID: 4340548
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunobiologic aspects of the brain and human gliomas. A review.
    Wikstrand CJ; Bigner DD
    Am J Pathol; 1980 Feb; 98(2):517-68. PubMed ID: 6986786
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunological study of glioma. (2) Changes of immunological responses during treatment].
    Sobue H; Tanimura K; Terabayashi T; Minagawa M; Inoue K
    No To Shinkei; 1976 Jan; 28(1):87-93. PubMed ID: 194609
    [No Abstract]   [Full Text] [Related]  

  • 17. Serological analysis of tumor antigens in malignant glioma patients.
    Yoshida S; Tanaka R; Ono K
    Neurol Med Chir (Tokyo); 1991 Sep; 31(9):559-62. PubMed ID: 1723168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responses in patients with gliomas.
    Brooks WH; Caldwell HD; Mortara RH
    Surg Neurol; 1974 Nov; 2(6):419-23. PubMed ID: 4372736
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunobiology of primary neoplasms of the C.N.S. Preliminary results.
    Gerosa M; Raumer R; Amadori G; Semenzato G; Gasparotto G; Carteri A
    J Neurosurg Sci; 1979; 23(3):165-75. PubMed ID: 316820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressor cell activity triggered by tumor associated antigen in patients with intracranial glioma.
    Lin SM; Hung CC
    Taiwan Yi Xue Hui Za Zhi; 1986 Jan; 85(1):8-18. PubMed ID: 2940327
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.